top of page

SGB Study to Treat Anxiety: A Case Series of 285 Patients

  • Jun 1, 2023
  • 1 min read

Updated: Jun 17

Anxiety improvement after Stellate Ganglion Block (SGB), with mean GAD-7 scores decreasing by 50% at one month in a 285-patient case series.

In this 2023 SGB study of 285 patients by Lynch, stellate ganglion block (SGB) was associated with a significant reduction in anxiety symptoms, with mean GAD-7 scores dropping by more than half within one week and remaining improved at one month.



 
 
bottom of page